Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanne G Swinnen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Diabetes Care|October 31, 2009
Insulin therapy for type 2 diabetesSanne G Swinnen, Joost B Hoekstra, J Hans DeVries
The Cochrane Database of Systematic Reviews|July 8, 2011
Insulin detemir versus insulin glargine for type 2 diabetes mellitusSanne G Swinnen, Airin Cr Simon, Frits Holleman, et al.
Diabetes Care|March 5, 2010
A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugsSanne G Swinnen, Marie-Paule Dain, Ronnie Aronson, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Diabetes Care|October 31, 2009
Insulin therapy for type 2 diabetesSanne G Swinnen, Joost B Hoekstra, J Hans DeVries
The Cochrane Database of Systematic Reviews|July 8, 2011
Insulin detemir versus insulin glargine for type 2 diabetes mellitusSanne G Swinnen, Airin Cr Simon, Frits Holleman, et al.
Diabetes Care|March 5, 2010
A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugsSanne G Swinnen, Marie-Paule Dain, Ronnie Aronson, et al.
Pageof 1